# OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
Canonical URL: https://biopharmsignal.com/news/OPKO/opko-health-s-modex-therapeutics-will-present-data-demonstrating-in-vivo-car-t-cell-generation-and-deep-b-cell-depletion-in-preclinical-studies
Ticker: OPKO
Company: Opko
Source: Opko
Published: 2026-05-12 12:00 EST
Original Source URL: https://www.opko.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-12 12:00 EST — [OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies](https://biopharmsignal.com/news/OPKO/opko-health-s-modex-therapeutics-will-present-data-demonstrating-in-vivo-car-t-cell-generation-and-deep-b-cell-depletion-in-preclinical-studies) — Source: Opko
- 2026-04-30 12:00 EST — [BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform](https://biopharmsignal.com/news/OPKO/bioreferencer-launches-bioreference-directtm-expanding-access-to-consumer-initiated-diagnostic-testing-through-a-fully-integrated-digital-platform) — Source: Opko
- 2026-04-08 12:00 EST — [OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19](https://biopharmsignal.com/news/OPKO/opko-health-s-modex-therapeutics-initiates-clinical-trial-of-mdx2301-for-the-prevention-of-covid-19) — Source: Opko
- 2026-02-27 13:00 EST — [OPKO Health to Participate in the Jefferies Biotech on the Beach Summit](https://biopharmsignal.com/news/OPKO/opko-health-to-participate-in-the-jefferies-biotech-on-the-beach-summit) — Source: Opko
- 2026-02-26 21:05 EST — [OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results](https://biopharmsignal.com/news/OPKO/opko-health-reports-fourth-quarter-2025-business-highlights-and-financial-results) — Source: Opko
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)